Hormone treatment and muscle anabolism during aging: Androgens

作者: E. Lichar Dillon , William J. Durham , Randall J. Urban , Melinda Sheffield-Moore

DOI: 10.1016/J.CLNU.2010.03.010

关键词:

摘要: Aging is associated with a gradual decline in circulating testosterone concentrations and decreased musculature men. While administration often considered when symptoms of hypogonadism are presented, the long-term effects androgen use on muscle physiology not yet fully understood. The definition men remains obscure but generally indicated by total less than threshold value 300-500 ng/dL. Androgen replacement therapy safe women low endogenous concentrations. development selective receptor modulators (SARMs) may provide additional options treatment while lowering potential side use. administration, either alone or combination other treatments, can be successful improving mass increasing protein anabolism reducing catabolism women. Further research necessary to optimize anabolic anticatabolic properties androgens for prevention loss

参考文章(70)
Alvaro Morales, Jeremy P. W. Heaton, Androgen Deficiency in the Aging Male Oral Pharmacotherapy for Male Sexual Dysfunction. pp. 279- 299 ,(2005) , 10.1385/1-59259-871-4:279
Stephen Lazarou, Luis Reyes‐Vallejo, Abraham Morgentaler, ORIGINAL RESEARCH—ENDOCRINOLOGY: Wide Variability in Laboratory Reference Values for Serum Testosterone The Journal of Sexual Medicine. ,vol. 3, pp. 1085- 1089 ,(2006) , 10.1111/J.1743-6109.2006.00334.X
Arthur A. Vandenbark, Arthur A. Vandenbark, Halina Offner, Jeanette C. Schuster, Bruce F. Bebo, Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. Journal of Immunology. ,vol. 162, pp. 35- 40 ,(1999)
Stephanie M. Liva, Rhonda R. Voskuhl, Testosterone Acts Directly on CD4+ T Lymphocytes to Increase IL-10 Production Journal of Immunology. ,vol. 167, pp. 2060- 2067 ,(2001) , 10.4049/JIMMUNOL.167.4.2060
Raymond W. Thompson, Joseph M. McClung, Kristen A. Baltgalvis, J. Mark Davis, James A. Carson, Modulation of overload-induced inflammation by aging and anabolic steroid administration. Experimental Gerontology. ,vol. 41, pp. 1136- 1148 ,(2006) , 10.1016/J.EXGER.2006.08.013
Kishore M. Lakshman, Shalender Bhasin, Christopher Corcoran, Lisa A. Collins-Racie, Lioudmila Tchistiakova, S. Bradley Forlow, Katie St. Ledger, Michael E. Burczynski, Andrew J. Dorner, Edward R. LaVallie, Measurement of myostatin concentrations in human serum: Circulating concentrations in young and older men and effects of testosterone administration ☆ Molecular and Cellular Endocrinology. ,vol. 302, pp. 26- 32 ,(2009) , 10.1016/J.MCE.2008.12.019
Chrisandra L. Shufelt, Glenn D. Braunstein, Safety of testosterone use in women Maturitas. ,vol. 63, pp. 63- 66 ,(2009) , 10.1016/J.MATURITAS.2009.01.012
Elizabeth M. Wilson, Muscle-Bound? A Tissue-Selective Nonsteroidal Androgen Receptor Modulator Endocrinology. ,vol. 148, pp. 1- 3 ,(2007) , 10.1210/EN.2006-1368
Hui-Nan Yin, Jia-Ke Chai, Yong-Ming Yu, Chuan-An Shen, Yan-Qiu Wu, Yong-Ming Yao, Hui Liu, Li-Ming Liang, Ronald G. Tompkins, Zhi-Yong Sheng, Regulation of signaling pathways downstream of IGF-I/insulin by androgen in skeletal muscle of glucocorticoid-treated rats. Journal of Trauma-injury Infection and Critical Care. ,vol. 66, pp. 1083- 1090 ,(2009) , 10.1097/TA.0B013E31817E7420
Anne R. Cappola, Sarah J. Ratcliffe, Shalender Bhasin, Marc R. Blackman, Jane Cauley, John Robbins, Joseph M. Zmuda, Tamara Harris, Linda P. Fried, Determinants of Serum Total and Free Testosterone Levels in Women over the Age of 65 Years The Journal of Clinical Endocrinology and Metabolism. ,vol. 92, pp. 509- 516 ,(2007) , 10.1210/JC.2006-1399